PRCT Procept BioRobotics Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PRCT

Price (delayed)

$18.09

Market cap

$1.04B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.94

Enterprise value

$885.67M

?
Relative Growth: Rel. Growth: 53
Relative Strength: Rel. Strength: 11
Relative Valuation: Rel. Valuation: 16
Relative Profitability: Rel. Profitability: 24
Highlights
Procept BioRobotics's revenue has increased by 23% YoY and by 4.8% QoQ
PRCT's gross profit is up by 23% year-on-year and by 5% since the previous quarter
The quick ratio has declined by 32% year-on-year and by 2.6% since the previous quarter
Procept BioRobotics's net income has decreased by 30% YoY and by 7% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.procept-biorobotics.com
Peers: ISRG GMED INSP PEN

Key stats

What are the main financial stats of PRCT

PRCT stock price

How has the Procept BioRobotics stock price performed over time
Intraday
-1.84%
1 week
-6.94%
1 month
-16.56%
1 year
-53.79%
YTD
-42.5%
QTD
-19.88%

Financial performance

How have Procept BioRobotics's revenue and profit performed over time
Revenue
$337.34M
Gross profit
$216.65M
Operating income
-$114.23M
Net income
-$109.76M
Gross margin
64.2%
Net margin
-32.5%
Procept BioRobotics's net income has decreased by 30% YoY and by 7% QoQ
PRCT's operating income is down by 24% year-on-year and by 4.8% since the previous quarter
Procept BioRobotics's revenue has increased by 23% YoY and by 4.8% QoQ
PRCT's gross profit is up by 23% year-on-year and by 5% since the previous quarter

Price vs fundamentals

How does PRCT's price correlate with its fundamentals

Growth

What is Procept BioRobotics's growth rate over time

Valuation

What is Procept BioRobotics stock price valuation
P/E
N/A
P/B
3.03
P/S
3.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.63
Procept BioRobotics's EPS has decreased by 26% YoY and by 7% QoQ
PRCT's P/B is 60% below its 5-year quarterly average of 7.7 and 32% below its last 4 quarters average of 4.5
The equity has declined by 12% year-on-year and by 2.2% since the previous quarter
The stock's price to sales (P/S) is 81% less than its 5-year quarterly average of 16.3 and 39% less than its last 4 quarters average of 5.1
Procept BioRobotics's revenue has increased by 23% YoY and by 4.8% QoQ

Efficiency

How efficient is Procept BioRobotics business performance
The ROE has contracted by 29% YoY and by 10% from the previous quarter
Procept BioRobotics's ROA has decreased by 28% YoY and by 9% from the previous quarter
PRCT's ROIC is down by 19% YoY and by 3.9% QoQ
Procept BioRobotics's return on sales has decreased by 7% YoY

Dividends

What is PRCT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRCT.

Financial health

How did Procept BioRobotics financials performed over time
The quick ratio has declined by 32% year-on-year and by 2.6% since the previous quarter
Procept BioRobotics's current ratio has decreased by 29% YoY and by 2.7% from the previous quarter
The debt is 77% smaller than the equity
The equity has declined by 12% year-on-year and by 2.2% since the previous quarter
The debt to equity has increased by 10% year-on-year and by 4.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.